Skip to content
ASK A VET

Tick-Borne Disease Treatment Calculator

Pick the region and enter the test results. For each tick-borne infection found in a dog or cat, the tool gives the drug, the dose in mg/kg and in mg at this weight (mL for injections), the route, how often, how long, the start and end dates and a dated recheck plan, with the region's tests, drug availability and reporting rules. Co-infections get one merged drug list. A blank result reads not tested, never negative.

Before you begin: take EDTA blood for PCR before the first doxycycline dose, because the drug can make PCR negative, and test for the other tick-borne infections: they often come together.

Step 1

Patient

Dogs and cats. The weight is used for every dose; the patient label is used only in the note and is never stored.

Species

A weight that fits the other unit better, a cat weight typed in grams, or a thousands comma (1,200) is asked about before anything is worked out.

Step 2

Region

Where the patient lives or caught the infection. Each region carries its own infections, tests, drug availability and reporting rules.

Step 3

The picture

This decides whether an antibody result alone gives a course, or the tests and checks to run first.

The picture
Step 4

Test results

One row per infection this region and species carry. Leave a test at Not tested if it was not run: it is never read as negative. Babesia and Hepatozoon drugs show only once the parasite is seen on a smear or found by PCR.

Step 5

Bloods (optional)

Used for the transfusion check and the platelet line. A PCV typed as a fraction (0.15) or platelets typed per microliter (150000) are asked about.

Step 6

Patient flags

Tick any that apply. Each one says which plans it changes.

Step 7

Drug choices and start date

The start date comes from this device and can be changed; every course and recheck date counts from it.

Result

Treatment plan and note

Updates with every change. Copy, email or print the note for the clinical record.

The plan will appear here

Enter the weight, region and picture.

For veterinarians and veterinary nurses. Treatment doses, course lengths and recheck plans for tick-borne infections in dogs and cats in Asia and Australia, from published guidelines and trials; it does not make the diagnosis. Babesia and Hepatozoon drugs show only after the parasite is seen on a smear or found by PCR. Several of these drugs are human or cattle products used off-label in dogs: check every dose against the product you dispense.

How this tool works

Tick-borne disease treatment guide

Quick answer

Pick the species, weight and region, say whether the patient is sick, well but positive on screening, or relapsing, and enter each test result. The tool reads each infection as found (seen on a smear or by PCR), antibody positive only, negative or not tested, and builds a plan card for each one it can treat, a merged drug list, a dated recheck plan, the red flags, and the region's tests, drug availability, reporting rules and tick control. The same plan comes out as a treatment note to copy, email or print.

How to use the tool

  1. Pick dog or cat and type the weight in kg or lb. A weight outside the range for the species asks Did you mean ...? (for example a cat typed in grams, or a dog typed in lb with kg selected), and a thousands comma (1,200) asks Did you mean 1200? Nothing is worked out until it is retyped.
  2. Pick the region. Traveled or imported asks where the patient came from and where it is now, and uses the infections of both.
  3. Pick the picture: sick, well but positive on a screening test (a blood donor, an import or a routine check), or relapse and not responding.
  4. Enter each test that was run. A test left at Not tested is never read as negative. Tick Not tested yet when you suspect tick-borne disease but have no results: you get the region's tests and, for dogs, the start-on-suspicion doxycycline line.
  5. Add the PCV, platelets and urine protein to creatinine ratio if you have them, and tick the patient flags. Each flag lists the plans it changes.
  6. Where imidocarb is in the plan, type the vial strength for the dose in mL. Then read the plan, pick Full or Short for the note, and Copy, Email or Print.

Confirm before any Babesia or Hepatozoon dose

An antibody test cannot name the Babesia species, and a positive one can mean a past infection. Look at a stained blood smear first and send PCR when it is negative; PCR names the species before you choose the drug. Until the parasite is seen or found, the tool gives the test to run next and no dose. A transfusion step can still show: transfusion is decided on the signs more than the number.

Doses, course lengths and rechecks this tool uses

InfectionDrug and doseHow longRecheck
Ehrlichia canis, Anaplasma platys, A. phagocytophilum (dogs)Doxycycline 10 mg/kg by mouth once a day, or 5 mg/kg every 12 hours, with food and water; start on suspicion28 daysPlatelets at 1 and 4 weeks and 1 to 2 months after the course; E. canis PCR 2 weeks after the course, then 2 months later
Large Babesia (B. vogeli)Atropine 0.02 to 0.04 mg/kg under the skin 15 minutes ahead, then imidocarb 6.6 mg/kg into the muscle or under the skinRepeated once in 14 daysSecond dose at day 14; PCV and smear then
Babesia gibsoni and other small BabesiaAtovaquone 13.3 mg/kg every 8 hours with a fatty meal, plus azithromycin 10 mg/kg once a day; or clindamycin 25 mg/kg, metronidazole 15 mg/kg and doxycycline 5 mg/kg, each every 12 hours10 days; three antibiotics at least 6 weeks, often 3 monthsPCR 60 and 90 days after the last dose
Hepatozoon canisImidocarb 5 to 6 mg/kg under the skin every 14 days after atropine, until no parasites on 2 smears, with doxycycline 10 mg/kg once a dayDoxycycline 21 days (longer when another plan also needs doxycycline: the drug list gives the longest course)Blood count and parasite load at 14, 28 and 56 days; then PCR
Lyme (Southeast and East Asia)Doxycycline 10 mg/kg a day in total; amoxicillin 20 mg/kg three times a day for a pregnant bitch or young puppy (from the Lyme antibiotic table; no source covers pregnancy); ceftriaxone 25 mg/kg once a day for a dog that cannot take tablets4 weeks; amoxicillin 30 days; ceftriaxone 14 to 30 daysUrine protein at least 2 to 3 times a year
HemoplasmaDogs: usually a finding; clinical disease gets supportive care and doxycycline. Cats: doxycycline 10 mg/kg once a day or 5 mg/kg every 12 hoursDogs at least 2 weeks; cats 2 to 4 weeksQuantitative PCR can track response in cats
Cats: Ehrlichia or AnaplasmaDoxycycline 10 mg/kg once a day (little cat data); follow every dose with food or waterEhrlichia 28 days; Anaplasma 14 to 28 daysUse PCR in cats
Cats: Cytauxzoon (Asia)Atovaquone 15 mg/kg every 8 hours with azithromycin 10 mg/kg once a day, plus heparin, fluids and supportive care (a US trial)10 daysNone set in the sources

The dog doses and course lengths for Ehrlichia, Anaplasma, Babesia and Hepatozoon canis match the approved ASK A VET™ Parasite Treatment Calculator. Metronidazole is refused in pregnancy, under 12 weeks old, while nursing and with nervous system signs (atovaquone with azithromycin instead), and halved with liver disease. Babesia and Hepatozoon felis in cats get no dose: no treatment trial was found.

Regions

RegionCoversDog infections listed
Australia: northern and other Ehrlichia canis areasNorthern WA, all of the NT, northern SA (Port Augusta and north), north-west and north Queensland including Townsville and the Tablelands (Queensland list as of February 2024)E. canis, A. platys, B. vogeli, B. gibsoni, H. canis (exotic), hemoplasma
Australia: rest of the countryEverywhere else in AustraliaB. gibsoni, B. vogeli, E. canis (dogs moved from the north), A. platys, H. canis (exotic), hemoplasma
Southeast AsiaThailand, Indonesia, the Philippines, Vietnam, Malaysia, SingaporeE. canis, A. platys, B. vogeli, B. gibsoni, H. canis, hemoplasma, Lyme (rare)
East AsiaChina, Hong Kong, Taiwan, Japan, South KoreaB. gibsoni, B. vogeli, E. canis, A. platys, A. phagocytophilum (Korea), H. canis, hemoplasma, Lyme (rare)
South AsiaIndia, Sri Lanka, Nepal, BangladeshE. canis, A. platys, B. gibsoni, B. vogeli, H. canis, hemoplasma
Traveled or importedPick where it came from and where it is nowThe infections of both regions

Cats: Australia has no known tick-borne protozoan infection of pet cats; Asian surveys found Cytauxzoon, Babesia and Hepatozoon felis in cats, and feline hemoplasmas occur everywhere.

The formula behind this calculator

  • Dose: mg/kg x weight in kg = mg. A weight typed in lb is divided by 2.2046 first.
  • Injection volume: mg / mg per mL = mL, rounded down to 0.01 mL under 1 mL and to 0.1 mL above; a dose range rounds its low end up and its high end down so both stay inside the range. A volume under 0.02 mL or over 8 mL is refused.
  • Dates: the start date is day 1 of a course, so a 28-day course ends on the start date plus 27 days; rechecks count from the start date or from the last dose.
  • Co-infections: each drug is listed once. Doxycycline takes the longest course of the plans that need it.

Limits

  • A negative smear rules nothing out, and a negative PCR means not found in this sample, not free of infection.
  • A positive antibody test means exposure, not necessarily disease now.
  • No free source gives a treatment for Rickettsia in dogs in Asia or Australia, so Rickettsia felis appears as a people-health note only.
  • Chloramphenicol, diminazene and rifampicin are not dosed: no dose source, a narrow safety margin, or specialist use only.
  • Drug registration in each Asian country was not checked. Tick paralysis is a toxin, not an infection: use the Snake Bite and Tick Paralysis Calculator.

Common questions

Why are the Babesia and Hepatozoon drugs hidden until a smear or PCR?

Because the drugs differ between the parasites and none of them is harmless. An antibody test cannot name the Babesia species and a positive one can mean a past infection, and the shape on a smear is a poor guide to species, so the tool asks for the parasite seen on a smear or found by PCR before it shows any Babesia or Hepatozoon dose. An antibody result alone gives the test to run next.

Should I treat a well dog that is antibody positive for Ehrlichia canis?

There is no data on whether treating helps. A positive antibody test means past or current infection, not necessarily disease now, and in endemic areas many healthy dogs are positive. Confirm with PCR: DNA shows active infection. The tool gives no course by default for a well, antibody-positive dog; it gives the PCR, the paired antibody test and the blood count checks, and leaves the decision with you and the owner.

How long is the doxycycline course, and why is there one line for co-infections?

For Ehrlichia canis and Anaplasma the tool uses 10 mg/kg by mouth once a day, or 5 mg/kg every 12 hours, for 28 days, as the approved ASK A VET™ Parasite Treatment Calculator. Hepatozoon canis alone gets 21 days. When several plans need doxycycline, the drug list gives one doxycycline line at the longest course, so it is never given twice.

When should I recheck the PCR after Babesia gibsoni treatment?

At 60 and 90 days after the last dose; two negatives count as success. A shorter plan at 30 and 60 days agreed in most dogs, but a negative at day 30 can turn positive later, so the tool keeps 60 and 90 days. A negative PCR is not proof of cure.

Is Ehrlichia canis notifiable in Australia?

The national listing has changed: the AVA (May 2024) says it is no longer nationally notifiable, while the national pages still say to report to the state or territory authority as each requires. New South Wales has a legal duty to notify within one working day, South Australia requires vets to report any suspected clinical case immediately, and Victoria asks vets to notify suspected cases. The tool gives the rule for each state and the EAD hotline, 1800 675 888.

Do antibody results show whether treatment worked?

No. Ehrlichia canis antibody levels usually fall over 6 to 9 months and can stay positive for years, and antibodies to Babesia gibsoni usually stay positive after treatment. Aim for a negative PCR, not a negative antibody test, and follow the platelet count.

What does the tool give for cats?

Cat lines appear only where a published cat source exists. Hemoplasma: doxycycline 10 mg/kg once a day, or 5 mg/kg every 12 hours, for 2 to 4 weeks. Suspected ehrlichiosis or anaplasmosis: doxycycline with little cat data. Use PCR in cats: the in-clinic 4-pathogen test is not a cat test. No treatment trial for a tick-borne protozoan of cats in Asia or Australia was found, so Babesia and Hepatozoon felis in cats get no dose.

Which tick control protects against Ehrlichia canis?

E. canis can pass within 3 hours of tick attachment, faster than most isoxazolines kill ticks, so a repel-and-kill collar or spot-on is the main protection and tablets alone are not enough. Dogs with suspected or confirmed ehrlichiosis need lifelong tick control, even with no ticks seen, and the home treated.

Is anything I type stored or sent?

No. The plan and the note are built in your browser and are not saved or sent anywhere. The patient label is used only in the note you copy, email or print.

Sources

  1. Abd Rani PA, Irwin PJ, Coleman GT, Gatne M, Traub RJ. A survey of canine tick-borne diseases in India. Parasit Vectors. 2011;4:141. doi.org/10.1186/1756-3305-4-141
  2. Agriculture Victoria. Canine monocytic ehrlichiosis in Victoria: biosecurity advisory (issued 16 June 2022). agriculture.vic.gov.au
  3. Agriculture Victoria. Ehrlichiosis (page last updated 28 Apr 2026; read 2026-11-17). agriculture.vic.gov.au
  4. Almendros A, Burchell R, Wierenga J. An alternative combination therapy with metronidazole, clindamycin and doxycycline for Babesia gibsoni (Asian genotype) in dogs in Hong Kong. J Vet Med Sci. 2020;82(9):1334-1340. doi.org/10.1292/jvms.20-0209
  5. Almendros A, Choi YR, Leung TL, et al. Low prevalence of Babesia hongkongensis infection in community and privately-owned cats in Hong Kong. Ticks Tick Borne Dis. 2024;15(1):102278. doi.org/10.1016/j.ttbdis.2023.102278
  6. Almendros A, et al. Babesia gibsoni infection in a cat with immune-mediated haemolytic anaemia and thrombocytopenia. Animals (Basel). 2023;13(13):2128. doi.org/10.3390/ani13132128
  7. Aryal S, et al. Comprehensive study of ticks and tick-borne diseases in dogs in Nepal: molecular identification, risk analysis and hematological alterations. BMC Vet Res. 2025;21. doi.org/10.1186/s12917-025-04777-x
  8. Atapattu U, Colella V, Worsley A, Huggins LG, Wiethoelter A, Traub RJ. Prevalence, distribution, and factors associated with vector-borne pathogen infections in pet dogs from different geoclimatic zones in Sri Lanka. Transbound Emerg Dis. 2023;2023:9467314. doi.org/10.1155/2023/9467314
  9. Atapattu U, et al. Knowledge, attitude, and practices of veterinarians towards canine vector-borne pathogens in Sri Lanka. PLoS Negl Trop Dis. 2024;18:e0012365. doi.org/10.1371/journal.pntd.0012365
  10. Australian Government Department of Agriculture, Fisheries and Forestry. Canine monocytic ehrlichiosis: a guide for veterinarians (BIO067.0523). Canberra: DAFF; 2023. agriculture.gov.au
  11. Australian Government Department of Agriculture, Fisheries and Forestry. Ehrlichiosis: additional veterinary guidelines for managing CME in Australia (web page, read 2026-11-17). agriculture.gov.au
  12. Australian Government Department of Agriculture, Fisheries and Forestry. National list of notifiable animal diseases (web page, read 2026-11-17). agriculture.gov.au
  13. Australian Pesticides and Veterinary Medicines Authority. Permit PER87537: minor use and supply of unregistered buparvaquone and primaquine products for theileriosis in calves, in force 2020 to 2030. permits.apvma.gov.au
  14. Australian Pesticides and Veterinary Medicines Authority. PubCRIS dataset of registered agricultural and veterinary chemical products (data.gov.au, updated 2026-11-12), searched 2026-11-17. data.gov.au
  15. Australian Veterinary Association. Ehrlichia (policy and advocacy, emergency animal diseases; updated May 2024; read 2026-11-17). ava.com.au
  16. Baneth G. Antiprotozoal treatment of canine babesiosis. Vet Parasitol. 2018;254:58-63. doi.org/10.1016/j.vetpar.2018.03.001
  17. Baneth G. Perspectives on canine and feline hepatozoonosis. Vet Parasitol. 2011;181(1):3-11. doi.org/10.1016/j.vetpar.2011.04.015
  18. Barker EN, Langton DA, Helps CR, Brown G, Malik R, Shaw SE, Tasker S. Haemoparasites of free-roaming dogs associated with several remote Aboriginal communities in Australia. BMC Vet Res. 2012;8:55. doi.org/10.1186/1746-6148-8-55
  19. Birkenheuer AJ, Levy MG, Breitschwerdt EB. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med. 2004;18(4):494-498. doi.org/10.1892/0891-6640(2004)18<494:eocaaa>2.0.co;2
  20. Business Queensland (Queensland Government). Ehrlichia canis information for veterinarians (web page, read 2026-11-17). business.qld.gov.au
  21. Chan K, et al. Clinical and clinicopathological features of 108 dogs infected with Babesia gibsoni in Hong Kong. Animals (Basel). 2025;15(5):645. doi.org/10.3390/ani15050645
  22. Checa R, Montoya A, Ortega N, et al. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm. Parasit Vectors. 2017;10:145. doi.org/10.1186/s13071-017-2049-0
  23. Cohn LA, Birkenheuer AJ, Brunker JD, Ratcliff ER, Craig AW. Efficacy of atovaquone and azithromycin or imidocarb dipropionate in cats with acute cytauxzoonosis. J Vet Intern Med. 2011;25(1):55-60. doi.org/10.1111/j.1939-1676.2010.0646.x
  24. Colella V, et al. Zoonotic vectorborne pathogens and ectoparasites of dogs and cats in Eastern and Southeast Asia. Emerg Infect Dis. 2020;26(6):1221-1233. doi.org/10.3201/eid2606.191832
  25. De Tommasi AS, Giannelli A, de Caprariis D, et al. Failure of imidocarb dipropionate and toltrazuril/emodepside plus clindamycin in treating Hepatozoon canis infection. Vet Parasitol. 2014;200(3-4):242-245. doi.org/10.1016/j.vetpar.2013.12.013
  26. Department of Primary Industries and Regional Development WA. Ehrlichiosis (updated 20 January 2025; read 2026-11-17). dpird.wa.gov.au
  27. Do T, Kamyingkird K, Chimnoi W, Inpankaew T. Evaluation of hematological alteration of vector-borne pathogens in cats from Bangkok, Thailand. BMC Vet Res. 2021;17. doi.org/10.1186/s12917-020-02737-1
  28. Dubey JP, et al. Hepatozoon infections in domestic and wild Carnivora: etiology, prevalence, clinical disease, diagnosis and treatment. Parasit Vectors. 2025;18. doi.org/10.1186/s13071-025-06977-8
  29. Gerber K, Picard JA, Elliman J, Joone CJ, Indrawirawan Y, Constantinoiu CC. Prevalence of vector-borne pathogens Ehrlichia canis, Babesia spp. and Dirofilaria immitis in dogs in Townsville, far north Queensland. Aust Vet J. 2025;103(7):430-432. doi.org/10.1111/avj.13450
  30. German AJ, Cannon MJ, Dye C, et al. Oesophageal strictures in cats associated with doxycycline therapy. J Feline Med Surg. 2005;7(1):33-41. Abstract only. doi.org/10.1016/j.jfms.2004.04.001
  31. Greay TL, et al. Endemic, exotic and novel apicomplexan parasites detected during a national study of ticks from companion animals in Australia. Parasit Vectors. 2018;11. doi.org/10.1186/s13071-018-2775-y
  32. Hii SF, Kopp SR, Abdad MY, Thompson MF, O'Leary CA, Rees RL, Traub RJ. Molecular evidence of Rickettsia felis infection in dogs from Northern Territory, Australia. Parasit Vectors. 2011;4:198. doi.org/10.1186/1756-3305-4-198
  33. IDEXX Laboratories. In-clinic 4-pathogen antibody test kit insert (heartworm antigen; Anaplasma, Borrelia burgdorferi and Ehrlichia antibodies), as reproduced on Drugs.com (read 2026-11-17). drugs.com
  34. Iguchi A, Soma T, Xuan X. Further epidemiological survey for atovaquone resistant related gene of Babesia gibsoni in Japan during 2015-2018. J Vet Med Sci. 2020;82(11):1700-1703. doi.org/10.1292/jvms.20-0382
  35. Inokuma H, Beppu T, Okuda M, Shimada Y, Sakata Y. Epidemiological survey of Anaplasma platys and Ehrlichia canis using ticks collected from dogs in Japan. Vet Parasitol. 2003;115(4):343-348. Abstract only. doi.org/10.1016/s0304-4017(03)00238-3
  36. Irwin PJ, Robertson ID, Westman ME, Perkins M, Straubinger RK. Searching for Lyme borreliosis in Australia: results of a canine sentinel study. Parasit Vectors. 2017;10:114. doi.org/10.1186/s13071-017-2058-z
  37. Irwin PJ. Canine babesiosis: from molecular taxonomy to control. Parasit Vectors. 2009;2(Suppl 1):S4. doi.org/10.1186/1756-3305-2-S1-S4
  38. Irwin PJ. The zoonotic potential of Anaplasma platys and Ehrlichia canis with a focus on these infections in Australia. Report for AMRRIC, November 2020. amrric.org
  39. Jayatilaka PS, et al. Canine vector-borne infections of working dogs of the Sri Lanka Air Force, and free roaming, and privately owned dogs. Sci Rep. 2024;14. doi.org/10.1038/s41598-024-71148-1
  40. Jefferies R, Ryan UM, Jardine J, Broughton DK, Robertson ID, Irwin PJ. Blood, Bull Terriers and Babesiosis: further evidence for direct transmission of Babesia gibsoni in dogs. Aust Vet J. 2007;85(11):459-463. doi.org/10.1111/j.1751-0813.2007.00220.x
  41. Jefferies R, Ryan UM, Muhlnickel CJ, Irwin PJ. Two species of canine Babesia in Australia: detection and characterization by PCR. J Parasitol. 2003;89(2):409-412. doi.org/10.1645/0022-3395(2003)089[0409:TSOCBI]2.0.CO;2
  42. Kabir A, et al. Epidemiology of canine ehrlichiosis and molecular characterization of Erhlichia canis in Bangladeshi pet dogs. PLoS One. 2024;19:e0314729. doi.org/10.1371/journal.pone.0314729
  43. Karasova M, Blanarova L, Tothova C, et al. Successful transmammary treatment of Babesia gibsoni infection in newborn puppies after the administration of Malarone, azithromycin, and artesunate to a lactating dam. Pathogens. 2024;13(7):562. doi.org/10.3390/pathogens13070562
  44. Kirk SK, Levy JK, Crawford PC. Efficacy of azithromycin and compounded atovaquone for treatment of Babesia gibsoni in dogs. J Vet Intern Med. 2017;31(4):1108-1112. doi.org/10.1111/jvim.14777
  45. Kock N, Kelly P. Massive hepatic necrosis associated with accidental imidocarb dipropionate toxicosis in a dog. J Comp Pathol. 1991;104(1):113-116. doi.org/10.1016/s0021-9975(08)80093-x
  46. Kumari A, et al. Molecular prevalence and clinical profiles of canine babesiosis in northern India. BMC Vet Res. 2026;22. doi.org/10.1186/s12917-026-05657-8
  47. Lin EC, Chueh LL, Lin CN, Hsieh LE, Su BL. The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni. Vet Parasitol. 2012;186(3-4):159-164. doi.org/10.1016/j.vetpar.2011.11.073
  48. Lin MY, Huang HP. Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni. Acta Vet Scand. 2010;52:27. doi.org/10.1186/1751-0147-52-27
  49. Littman MP, Gerber B, Goldstein RE, Labato MA, Lappin MR, Moore GE. ACVIM consensus update on Lyme borreliosis in dogs and cats. J Vet Intern Med. 2018;32(3):887-903. doi.org/10.1111/jvim.15085
  50. Lloret A, et al. Hepatozoonosis in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2015;17(7):642-644. doi.org/10.1177/1098612X15589879
  51. Manathunga T, Carbonara M, Nekouei O, et al. High prevalence of vector-borne pathogens in the blood of clinically healthy dogs in Hong Kong. Parasit Vectors. 2025;18. doi.org/10.1186/s13071-025-06853-5
  52. Merck Animal Health. Imidocarb dipropionate 120 mg/mL injection, FDA NADA 141-071, label Rev. 07/2025. DailyMed setid c7bfe38c-9249-466d-8718-8b8e82b99a8d. dailymed.nlm.nih.gov
  53. Muhlnickel CJ, Jefferies R, Morgan-Ryan UM, Irwin PJ. Babesia gibsoni infection in three dogs in Victoria. Aust Vet J. 2002;80(10):606-610. doi.org/10.1111/j.1751-0813.2002.tb10961.x
  54. Neer TM, Breitschwerdt EB, Greene RT, Lappin MR. Consensus statement on ehrlichial disease of small animals from the Infectious Disease Study Group of the ACVIM. J Vet Intern Med. 2002;16(3):309-315. doi.org/10.1111/j.1939-1676.2002.tb02374.x
  55. Nguyen VL, Colella V, Greco G, et al. Molecular detection of pathogens in ticks and fleas collected from companion dogs and cats in East and Southeast Asia. Parasit Vectors. 2020;13:420. doi.org/10.1186/s13071-020-04288-8
  56. Nguyen VL, Dantas-Torres F, Otranto D. Canine and feline vector-borne diseases of zoonotic concern in Southeast Asia. Curr Res Parasitol Vector Borne Dis. 2021;1:100001. doi.org/10.1016/j.crpvbd.2020.100001
  57. Northern Territory Government. Ehrlichiosis disease in dogs (web page, read 2026-11-17). nt.gov.au
  58. NSW Department of Primary Industries. Ehrlichia canis sample submission guidelines for veterinarians (web page, read 2026-11-17). dpi.nsw.gov.au
  59. NSW Department of Primary Industries. Ehrlichiosis (Ehrlichia canis) (web page, read 2026-11-17). dpi.nsw.gov.au
  60. Pasa S, Voyvoda H, Karagenc T, Atasoy A, Gazyagci S. Failure of combination therapy with imidocarb dipropionate and toltrazuril to clear Hepatozoon canis infection in dogs. Parasitol Res. 2011;109(3):919-926. doi.org/10.1007/s00436-011-2334-3
  61. Penzhorn BL, Oosthuizen MC. Babesia species of domestic cats: molecular characterization has opened Pandora's box. Front Vet Sci. 2020;7:134. doi.org/10.3389/fvets.2020.00134
  62. Primary Industries and Regions SA. Ehrlichiosis disease in dogs (web page, read 2026-11-17). pir.sa.gov.au
  63. Primary Industries and Regions SA. Ehrlichiosis: information for vets (web page, read 2026-11-17). pir.sa.gov.au
  64. Sainz A, Roura X, Miro G, Estrada-Pena A, Kohn B, Harrus S, Solano-Gallego L. Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe. Parasit Vectors. 2015;8:75. doi.org/10.1186/s13071-015-0649-0
  65. Sakuma M, Setoguchi A, Endo Y. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin. J Vet Intern Med. 2009;23(3):493-498. doi.org/10.1111/j.1939-1676.2009.0300.x
  66. Sasanelli M, Paradies P, Greco B, Eyal O, Zaza V, Baneth G. Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs based on parasitological and molecular evaluation methods. Vet Parasitol. 2010;171(3-4):194-199. doi.org/10.1016/j.vetpar.2010.03.042
  67. Shapiro AJ, Brown G, Norris JM, et al. Vector-borne and zoonotic diseases of dogs in North-west New South Wales and the Northern Territory, Australia. BMC Vet Res. 2017;13:238. doi.org/10.1186/s12917-017-1169-2
  68. Shepherdson E, Doust K, Hoopes JH, Barbosa AD, McNeill J. Estimated seroprevalence of Ehrlichia canis in dogs in a remote community in the Northern Territory, Australia. Aust Vet J. 2026;104(1-2):66-72. Abstract only. doi.org/10.1111/avj.70005
  69. Sikorski LE, Birkenheuer AJ, Holowaychuk MK, et al. Babesiosis caused by a large Babesia species in 7 immunocompromised dogs. J Vet Intern Med. 2010;24(1):127-131. doi.org/10.1111/j.1939-1676.2009.0440.x
  70. So-In C, et al. Molecular detection of vector-borne pathogens and their association with feline immunodeficiency virus and feline leukemia virus in domestic cats. Animals (Basel). 2025;15(14):2065. doi.org/10.3390/ani15142065
  71. Solano-Gallego L, Sainz A, Roura X, Estrada-Pena A, Miro G. A review of canine babesiosis: the European perspective. Parasit Vectors. 2016;9. doi.org/10.1186/s13071-016-1596-0
  72. Suh GH, Ahn KS, Ahn JH, et al. Serological and molecular prevalence of canine vector-borne diseases (CVBDs) in Korea. Parasit Vectors. 2017;10:146. doi.org/10.1186/s13071-017-2076-x
  73. Taira M, Tamai K, Igarashi H, et al. Genetic variants of Ehrlichia canis detected in two dogs in Japan. Vet Res Commun. 2026;50. doi.org/10.1007/s11259-026-11507-7
  74. Tasker S, Hofmann-Lehmann R, Belak S, et al. Haemoplasmosis in cats: European guidelines from the ABCD on prevention and management. J Feline Med Surg. 2018;20(3):256-261. doi.org/10.1177/1098612X18758594
  75. Tasker S. Hemotropic Mycoplasma. Vet Clin North Am Small Anim Pract. 2022;52(6):1319-1340. Abstract only. doi.org/10.1016/j.cvsm.2022.06.010
  76. Tauro A, et al. Metronidazole-induced neurotoxicity in 26 dogs. Aust Vet J. 2018;96(12):495-501. doi.org/10.1111/avj.12772
  77. Therapeutic Goods Administration. ARTG 66688: atovaquone 750 mg/5 mL oral liquid suspension (human medicine). tga.gov.au
  78. Zhang XL, et al. Molecular evidence of Babesia in pet cats in mainland China. BMC Vet Res. 2019;15. doi.org/10.1186/s12917-019-2214-0
  79. Zou FC, et al. Cytauxzoon felis infection in domestic cats, Yunnan Province, China, 2016. Emerg Infect Dis. 2019;25(2):353-354. doi.org/10.3201/eid2502.181182
  80. ASK A VET™ Parasite Treatment Calculator, approved version (library commit 9b856be0): Tick-borne infections, Other blood parasites and the drug table. askavet.com
  81. ASK A VET™ Hematology Helper, approved version (library commit 4e3e99b5): region lists and platelet reference intervals. askavet.com

ASK A VET™ · Tick-Borne Disease Treatment Calculator · By Dr Duncan Houston · Talk. Track. Trust.

Ask A Vet’s vet support lives in the app. See the app

Dr Duncan Houston
About the author

Dr Duncan Houston · BVSc, Veterinarian

Emergency & critical careGeneral practiceMobile vet careDog behaviour & trainingCat behaviourFounder & CEO

Dr Duncan Houston is an Australian veterinarian with experience in emergency, general-practice and mobile veterinary care. He is the founder of ASK A VET™. This guide is educational and is not a substitute for hands-on veterinary care.

Last reviewed